PGRCX
Price
$57.60
Change
-$0.24 (-0.41%)
Updated
Dec 1 closing price
Net Assets
1.04B
RNPCX
Price
$71.38
Change
-$0.59 (-0.82%)
Updated
Dec 1 closing price
Net Assets
163.52B
Interact to see
Advertisement

PGRCX vs RNPCX

Header iconPGRCX vs RNPCX Comparison
Open Charts PGRCX vs RNPCXBanner chart's image
BNY Mellon Worldwide Growth C
Price$57.60
Change-$0.24 (-0.41%)
VolumeN/A
Net Assets1.04B
American Funds New Perspective R3
Price$71.38
Change-$0.59 (-0.82%)
VolumeN/A
Net Assets163.52B
PGRCX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
PGRCX vs. RNPCX commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRCX is a StrongBuy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 164B vs. PGRCX (1.04B). RNPCX pays higher dividends than PGRCX: RNPCX (0.21) vs PGRCX (0.00). PGRCX was incepted earlier than RNPCX: PGRCX (30 years) vs RNPCX (24 years). PGRCX (1.89) is less costly to investors than RNPCX (1.06). RNPCX is a more actively managed with annual turnover of: 24.00 vs. PGRCX (13.83). RNPCX has a lower initial minimum investment than PGRCX: RNPCX (250) vs PGRCX (1000). RNPCX annual gain was more profitable for investors over the last year : 11.74 vs. PGRCX (-3.08). RNPCX return over 5 years is better than : 23.21 vs. PGRCX (4.58).
PGRCXRNPCXPGRCX / RNPCX
Total Expense Ratio1.891.06178%
Annual Report Gross Expense Ratio1.891.06178%
Fund Existence30 years24 years-
Gain YTD12.70518.82867%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B164B1%
Annual Yield % from dividends0.000.21-
Returns for 1 year-3.0811.74-26%
Returns for 3 years10.6142.8325%
Returns for 5 years4.5823.2120%
Returns for 10 years20.5888.5223%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKRO54.440.08
+0.15%
Akero Therapeutics
CBRE159.34-2.49
-1.54%
Cbre Group
JVA3.62-0.10
-2.69%
Coffee Holding Co
ETHZ9.45-1.22
-11.47%
ETHZilla Corporation
SUPX25.68-4.45
-14.77%
SuperX AI Technology Limited